Understanding Protein Cleanup in Heart Disease
Roles for endoplasmic reticulum associated degradation (ERAD) in Myocardial Proteostasis
This project explores how the heart manages its proteins to stay healthy, especially after a heart attack.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11128444 on NIH RePORTER |
What this research studies
Proteins are essential building blocks for our heart, and keeping them balanced is key to heart health. When this balance is off, especially in the heart's "protein factory" (the endoplasmic reticulum), it can lead to stress and damage, like what happens during a heart attack. Our team is looking into a specific cleanup process called ERAD, which helps remove damaged proteins from heart cells. We've found that a protein called Vimp acts like an antioxidant and helps this cleanup process, potentially reducing damage after a heart attack. By understanding how Vimp and ERAD work, we hope to find new ways to protect the heart.
Who could benefit from this research
Good fit: This foundational research is for anyone interested in the basic mechanisms of heart disease and future therapeutic developments.
Not a fit: Patients seeking immediate clinical interventions or direct treatment options would not directly benefit from this early-stage basic science.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that protect heart cells and reduce damage after events like heart attacks.
How similar studies have performed: While the general concept of protein balance in disease is established, the specific role of Vimp in ERAD and its antioxidant function in the ischemic heart is a novel area of investigation.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Glembotski, Chris — University of Arizona
- Study coordinator: Glembotski, Chris
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.